Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Ingre

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2022
Dying from ALS in Sweden: clinical status, setting, and symptomsStefan Sennfält, Ulf Kläppe, Sebastian Thams, et al.
Annals of Neurology|October 12, 2019
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-upSolmaz Yazdani, Daniela Mariosa, Niklas Hammar, et al.
JAMA Network Open|June 4, 2025
Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral SclerosisCharilaos Chourpiliadis, Anikó Lovik, Caroline Ingre, et al.
Annals of Clinical and Translational Neurology|April 22, 2024
Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptomsCharlotte Zejlon, Stefan Sennfält, Johannes Finnsson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 28, 2022
The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progressionStefan Sennfält, Ulf Kläppe, Sebastian Thams, et al.
Neurology|May 11, 2016
Depression in amyotrophic lateral sclerosisElin Roos, Daniela Mariosa, Caroline Ingre, et al.
Journal of Neurology|December 12, 2024
Exploring clinical chemistry markers in amyotrophic lateral sclerosis: insights into survival and disease trajectoriesIoannis Psychogios, Yihan Hu, Christina Seitz, et al.
Annals of Neurology|April 25, 2017
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohortDaniela Mariosa, Niklas Hammar, Håkan Malmström, et al.
Scientific Reports|August 10, 2020
No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control studyHakan Cetin, Jiangwei Sun, Catarina Almqvist, et al.
Journal of Neurology|June 9, 2024
Repeated cognitive assessments show stable function over time in patients with ALSLinn Öijerstedt, Juliette Foucher, Anikó Lovik, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2022
Dying from ALS in Sweden: clinical status, setting, and symptomsStefan Sennfält, Ulf Kläppe, Sebastian Thams, et al.
Annals of Neurology|October 12, 2019
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-upSolmaz Yazdani, Daniela Mariosa, Niklas Hammar, et al.
JAMA Network Open|June 4, 2025
Use of Common Psychiatric Medications and Risk and Prognosis of Amyotrophic Lateral SclerosisCharilaos Chourpiliadis, Anikó Lovik, Caroline Ingre, et al.
Annals of Clinical and Translational Neurology|April 22, 2024
Motor band sign is specific for amyotrophic lateral sclerosis and corresponds to motor symptomsCharlotte Zejlon, Stefan Sennfält, Johannes Finnsson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 28, 2022
The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progressionStefan Sennfält, Ulf Kläppe, Sebastian Thams, et al.
Neurology|May 11, 2016
Depression in amyotrophic lateral sclerosisElin Roos, Daniela Mariosa, Caroline Ingre, et al.
Journal of Neurology|December 12, 2024
Exploring clinical chemistry markers in amyotrophic lateral sclerosis: insights into survival and disease trajectoriesIoannis Psychogios, Yihan Hu, Christina Seitz, et al.
Annals of Neurology|April 25, 2017
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohortDaniela Mariosa, Niklas Hammar, Håkan Malmström, et al.
Scientific Reports|August 10, 2020
No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control studyHakan Cetin, Jiangwei Sun, Catarina Almqvist, et al.
Journal of Neurology|June 9, 2024
Repeated cognitive assessments show stable function over time in patients with ALSLinn Öijerstedt, Juliette Foucher, Anikó Lovik, et al.
Pageof 9